As Malaysia continues to evolve its healthcare landscape, focusing on digital integration, sustainable funding, and policy reforms, the conference aims to stimulate impactful discussions and forge strategic collaborations in the sector.

With the Health Transformation Office( HTO) implementing pivotal initiatives stemming from the Health White Paper, the event will spotlight how advancements in artificial intelligence are revolutionising patient care at the intersection of technology, policy, and investment.

CURATED CONFERENCE

The SEA Healthcare and Pharma Conference 2025 boasts guidance from a prestigious Steering Committee featuring prominent figures in the healthcare sector. Key members include:

• National Cancer Society Malaysia( NCSM) President & Non-Communicable Diseases( NCD) Malaysia Co-chairperson Dato’ Dr Saunthari Somasundaram

• Medical Device Authority( MDA) Chief Executive Officer Dr Muralitharan Paramasua

• Ministry of Health Malaysia’ s( MoH) Disease Control Division Deputy Director( NCD) Dr Noraryana Hassan

• Monash University Malaysia’ s Jeffrey Cheah School of Medicine

and Health Sciences Professor( Public Health and Policy) Eli Renganathan

• Frost & Sullivan Malaysia’ s Business Development Director Zainul Alam Abdul Kadir Their diverse expertise in medical research, clinical practice, public health policy, and industry leadership ensures that the conference agenda remains insightful and forward-thinking.

Delegates attending all three days of the conference will receive a certificate of attendance and be eligible for 20 Continuous Professional Development( CPD) points each from the Malaysian Medical Association( MMA) and the Malaysian Pharmacists Society( MPS).

Dr Noraryana remarked:“ This conference stands out for its comprehensive approach, covering the entire disease continuum with case studies in areas like diabetes and cancer while focusing on core health system pillars such as financing and system strengthening.

“ By bridging clinical practice with policy discussions, it offers valuable insights for a diverse range of stakeholders who can apply these learnings within their contexts across the region.”

TACKLING KEY ISSUES

The conference will feature a thorough programme addressing essential topics, including:

• Healthcare Transformation: Investigating innovative healthcare delivery models, policy shifts, and strategies to bolster health systems.

• Healthcare Financing and Policy: Delving into sustainable financing strategies, universal healthcare coverage, public-private partnerships, and value-based care delivery.

• Digital Health and AI Integration: Showcasing advancements in AI, digital health solutions, cloud computing, and their implications for patient care and accessibility. Among the distinguished speakers are KPJ Healthcare Bhd Regional Chief Executive Officer Hoo Ling Lee; MoH’ s Health Transformation Office( HTO) Chief Executive Officer Dr Yap Wei Aun; and MoH’ s Digital Health Director Dr Mahesh Appannan.

SEA Healthcare and Pharma Conference 2025 Organising Chairman and NCSM Managing Director Associate Professor Dr M Murallitharan stated:“ The conference is designed to address the most pressing developments in healthcare.

“ By exploring advancements in digital health, AI-driven innovations, and sustainable financing strategies, the event will catalyse transformative change in the regional healthcare landscape.”

SOCIAL IMPACT & BUSINESS INNOVATION

SEACare 2025 is redefining healthcare trade events by blending commercial interests with social impact and innovation.

For the first time, a portion of the proceeds will support cancer care and awareness, thereby reinforcing the event’ s commitment to promoting healthcare progress beyond

mere business interests.

Qube Executive Chairman Richard Teo commented:“ The SEA Healthcare and Pharma Conference 2025 marks a significant milestone as SEACare’ s first-ever conference, designed to foster critical dialogue, collaboration, and innovation.

“ This conference reflects SEACare’ s evolution not just as a platform for business opportunities but as a driver of transformative ideas that will shape the future of healthcare in the region.”

REGISTRATION INFORMATION

All passes grant full access to the conference with the following fee structure:

• HRD Claimable & Local / Self- Paid Delegate Pass( 3 days): RM 3,900

• Single-Day Pass: RM 1,300 per day( for the three days)

• International Delegate Pass( 3 days): USD 1,000( approximately RM 4,500) This landmark event, co-organised with the NCSM and Five Pillar Venture Capital Sdn Bhd, is set to unfold on Apr 23-25 at MITEC, Kuala Lumpur, running parallel to the SEACare 2025 exhibition.

This conference marks a significant advancement for SEACare, which Qube integrated into its operations in 2024.

The SEA Healthcare and Pharma Conference 2025 represents an unmissable opportunity for healthcare professionals, investors, and policymakers to drive meaningful change within. – The HEALTH